Navigation Links
Neurocrine Biosciences to Present at the UBS Global Life Sciences Conference
Date:9/22/2008

Live Audio Webcast Thursday, September 25, 2008

SAN DIEGO, Sept. 22 /PRNewswire-FirstCall/ -- Neurocrine Biosciences, Inc. (Nasdaq: NBIX) announced today that Kevin Gorman, President and Chief Executive Officer of Neurocrine Biosciences will be presenting at the UBS Global Life Sciences Conference at the Grand Hyatt in New York.

The live presentation takes place Thursday, September 25, 2008 at 10:00 a.m. Eastern Time (ET) /7:00 a.m. Pacific Time (PT). The presentation will be simultaneously webcast and may be accessed on the Company's website at http://www.neurocrine.com which will link you to the UBS Conference site. Once you have been linked to their site, you have the option to search by company name, or by time and date to access the webcast.

If you are unable to attend the webcast and would like further information on this announcement please contact the Investor Relations Department at Neurocrine Biosciences at (858) 617-7600. Viewers are encouraged to visit the website approximately 5 minutes prior to the presentation to download or install any necessary software. A replay of the presentation will be available approximately three hours after the conclusion of the live event and will be archived on the website for two weeks.

About Neurocrine

Neurocrine Biosciences, Inc. is a biopharmaceutical company focused on neurological and endocrine diseases and disorders. Our product candidates address some of the largest pharmaceutical markets in the world including endometriosis, irritable bowel syndrome (IBS), anxiety, depression, pain, diabetes, benign prostatic hyperplasia (BPH) and other neurological and endocrine related diseases and disorders. Neurocrine Biosciences, Inc. news releases are available through the Company's website via the internet at http://www.neurocrine.com


'/>"/>
SOURCE Neurocrine Biosciences, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Related biology technology :

1. Neurocrine Biosciences to Present at Thomas Weisel Healthcare Conference and the NewsMakers in the Biotech Industry Conference
2. Neurocrine Biosciences Reports Second Quarter 2008 Results
3. Neurocrine Biosciences Announces Conference Call and Webcast To Present Second Quarter 2008 Financial Results
4. Neurocrine Biosciences to Present at the 2008 Citi Investment Research Global Health Care Conference
5. Neurocrine Biosciences Announces Conference Call and Webcast to Present First Quarter 2008 Financial Results
6. Neurocrine Biosciences Announces Conference Call and Webcast to Present Fourth Quarter and Year End 2007 Financial Results
7. Neurocrine Announces Appointment of Kevin Gorman, Ph.D., as President and Chief Executive Officer
8. Neurocrine Announces Work Force Restructuring
9. Neurocrine Receives Approvable Letter for Indiplon Capsules with Additional Safety and Efficacy Data Required by FDA
10. Neurocrine Biosciences Announces Conference Call and Webcast to Provide Indiplon Update
11. Neurocrine Biosciences and Dainippon Sumitomo Pharma (DSP) Announce Agreement to Develop and Commercialize Indiplon in Japan
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/12/2017)... (PRWEB) , ... January 12, 2017 , ... Huffman ... of Stephen Beck, who will work in the company’s Lincoln office as a chemical ... processes to design control systems for customers in the life science manufacturing and water/wastewater ...
(Date:1/12/2017)... India , January 12, 2017 A new report published ... End Users - Global Opportunity Analysis and Industry Forecast, 2014-2022," projects that the global ... in 2015, growing at a CAGR of 15.07% during the forecast period. ... ... Logo ...
(Date:1/11/2017)... California (PRWEB) , ... January 11, 2017 , ... ... to support fertility specialists with accurate and reliable preimplantation genetic screening (PGS). , ... have achieved excellent results,” says Ovation Fertility Genetics Scientific Director Amy Jones, ...
(Date:1/11/2017)... ... January 11, 2017 , ... With ... healthcare systems more than $23.7 billion, healthcare systems are looking to provide ... the most common sepsis-causing pathogens are bacteria and the yeast pathogen Candida, which ...
Breaking Biology Technology:
(Date:1/6/2017)... 5, 2017  Delta ID Inc., a leader in ... for automotive at CES® 2017. Delta ID has collaborated ... demonstrate the use of iris scanning as a secure, ... driver in a car, and as a way to ... Delta ID and Gentex will demonstrate (booth ...
(Date:1/3/2017)... , Jan. 3, 2017 Onitor, provider of ... of Onitor Track, an innovative biometric data-driven program designed ... this month at the 2017 Consumer Electronics Show (CES) ... In the U.S., the World Health Organization (WHO), ... two-thirds of adults who are overweight or obese. WHO ...
(Date:12/20/2016)... -- The rising popularity of mobility services such ... significant interest in keyless access systems. Following the ... (BLE), biometrics and near-field communication (NFC) are poised ... technologies in the automotive industry. This evolution from ... opens the market to specialist companies such as ...
Breaking Biology News(10 mins):